+

WO2002039963A1 - Composition servant a traiter l'infection de l'ongle par un champignon et son procede d'utilisation - Google Patents

Composition servant a traiter l'infection de l'ongle par un champignon et son procede d'utilisation Download PDF

Info

Publication number
WO2002039963A1
WO2002039963A1 PCT/US2001/029438 US0129438W WO0239963A1 WO 2002039963 A1 WO2002039963 A1 WO 2002039963A1 US 0129438 W US0129438 W US 0129438W WO 0239963 A1 WO0239963 A1 WO 0239963A1
Authority
WO
WIPO (PCT)
Prior art keywords
nail
composition
copper
copper salt
tissue
Prior art date
Application number
PCT/US2001/029438
Other languages
English (en)
Inventor
Kenneth T. Zeiler
Original Assignee
Zeiler Kenneth T
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zeiler Kenneth T filed Critical Zeiler Kenneth T
Priority to MXPA03005380A priority Critical patent/MXPA03005380A/es
Priority to JP2002542338A priority patent/JP2004513905A/ja
Priority to CA002431651A priority patent/CA2431651A1/fr
Priority to EP01973268A priority patent/EP1341500A1/fr
Priority to AU2001292866A priority patent/AU2001292866A1/en
Publication of WO2002039963A1 publication Critical patent/WO2002039963A1/fr
Priority to US10/440,468 priority patent/US20040001791A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/34—Copper; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q3/00—Manicure or pedicure preparations

Definitions

  • This invention relates to a composition for treating fungal-infected human nails.
  • Nail fungal infections are caused by a fungal invasion of the keratinous structure of a fingernail or toe nail by a variety of fungi including Trychophyton sp., Microsporum sp., Epidermaphyton sp.; Candida sp., Trichosporon sp., Geotrichum sp., Scopulariopsis sp., Aspergillus sp., Acremonium sp., Fusarium sp., Phyllosticta sp., Hendersonula sp., and Cheatomium sp.
  • a fungal infected nail typically has a yellowish color that starts at one corner of the nail and spreads towards the cuticle. Over time, the infected nail presents as a thickened, lusterless, discolored nail, often with keratotic debris accumulated under the tip. Left untreated, the infected nail plate often becomes brittle, flaking, crumbling, friable, striated, deformed, separated, or completely destroyed. While onychomycosis is generally not painful, the unsightly appearance of the infected nail can be a source of embarrassment for most patients. For diabetics or immunosuppressed patients, an infected nail left untreated can result in severe infection.
  • Terbinafme hydrochloride is an oral preparation that prevents fungal growth by inhibiting squalene epoxidase and blocking fungal cell membrane synthesis.
  • Recommended treatment of terbinafme hydrochloride is six weeks for an infected fingernail and 12 weeks for an infected toe nail.
  • Topical antifungal agents include imidazoles or triazoles such as clotrimazole and ketoconazole, ciclopirox, amphotericin-B, gentian violet, resorcinol, and iodine.
  • imidazoles or triazoles such as clotrimazole and ketoconazole, ciclopirox, amphotericin-B, gentian violet, resorcinol, and iodine.
  • copper sulfate, copper carbonate, copper oxychloride, copper ammonium complex, copper oxide, copper hydroxide, copper naphthenates, and copper quinolinates have all been reported as effective fungicidal agents.
  • the antifungal properties of copper sulfate solutions have been known for over 230 years and were utilized to eliminate wheat bunt ⁇ Tilletia sp.) and potato blight, the cause of the Irish Potato Famine.
  • the oldest of the treatments to prevent the growth of Phytophthora infestans, the causative agent in potato blight are known as the Bordeaux mixture and the Burgundy mixture. Both solutions are prepared for spraying on potato plants to prevent blight according to a rigorous schedule synchronized to the fungus lifecycle.
  • Bordeaux mixture is most commonly used for potatoes and consists of a 2:1 mixture of copper sulfate and hydrated lime in 100 gallons of water.
  • a 1% Burgundy mixture consists of a 4:5 mixture of copper sulfate and sodium bicarbonate in 40 gallons of water.
  • organic farmers still utilize the Bordeaux mixture and the Burgundy mixture because they are safe, inexpensive, and easy to use.
  • Corliss, et al. disclose a hoof lotion that contains linseed oil as a dispersing agent, lanolin as a moisturizer, turpentine as a drying agent, iodine as an antiseptic agent, pine tar as a sticking agent, hydrogen peroxide as an antibacterial agent and copper sulfate as a fungicidal agent. Copper sulfate is 0.53% by weight of the hoof lotion. Corliss, et al. described the utility of the claimed hoof lotion as killing and preventing fungal growths and healing cracks, brittle surfaces and hoof dryness.
  • Undecylenic acid as well as its copper, calcium and zinc salts and combinations thereof have been reported as antifungal agents for use in the treatment of athlete' s foot (tinea pedis).
  • the foot creams, sprays, and ointments containing undecylenates have been limited to the treatment of skin fungal infections and specifically disclaimed as treatment for fungal nail infections.
  • a method for treating human onychomycosis comprising contacting fungal infected human nails with copper salts, preferably copper sulfate.
  • the invention is a nail composition comprising an effective antifungal amount of a copper salt effective for arresting fungal invasion in human nail tissue.
  • exemplary copper salts useful in the composition of the present invention include copper acetates, copper ammonium complexes, copper carbonates, copper perchlorates, copper halides, copper gluconates, copper oxyhalides, copper lactates, copper naphthenates, copper oxides, copper quinolinates copper salicylates, copper selenates, copper sulfates, and copper tartrates.
  • the copper salt is copper(II)sulfate.
  • the composition preferably comprises from 1% (weight/weight) to 32% (weight/weight) aqueous copper(II)sulfate; more preferably, 10% (weight/weight) aqueous copper(II)sulfate.
  • the composition is selected from the group consisting of a nail polish, acrylic nail product, gel nail product, cuticle softening solution, nail conditioning formulation, artificial nail product, and nail ornamental product.
  • the composition is a nail polish.
  • the nail composition further comprises a fixative.
  • the nail composition further comprises an adhesive.
  • the composition is a cuticle softening solution.
  • the composition can also release the copper salt over time using a controlled- release formulation.
  • the invention is a nail composition comprising an effective antifungal amount of a copper salt effective for arresting fungal growth on human nail tissue.
  • exemplary copper salts useful in the composition of the present invention include copper acetates, copper ammonium complexes, copper carbonates, copper perchlorates, copper halides, copper gluconates, copper oxyhalides, copper lactates, copper naphthenates, copper oxides, copper quinolinates copper salicylates, copper selenates, copper sulfates, and copper tartrates.
  • the copper salt is copper(II)sulfate.
  • the composition preferably comprises from 1% (weight/weight) to 32% (weight/weight) aqueous copper(II)sulfate; more preferably, 10% (weight/weight) aqueous copper(II)sulfate.
  • the composition is selected from the group consisting of a nail polish, acrylic nail product, gel nail product, cuticle softening solution, nail conditioning formulation, artificial nail product, and nail ornamental product.
  • the composition is a nail polish.
  • the nail composition further comprises a fixative.
  • the nail composition further comprises an adhesive.
  • the composition is a cuticle softening or nail conditioning solution.
  • the composition can also release the copper salt over time using a controlled-release formulation.
  • the present invention is use of a copper salt in the manufacture of an antifungal nail medicament comprising an effective antifungal amount of said copper salt effective for arresting fungal invasion in human nail tissue.
  • the present invention is use of a copper salt in the manufacture of an antifungal nail medicament comprising an effective antifungal amount of said copper salt effective for arresting fungal growth on human nail tissue.
  • the present invention is use of a copper salt in the manufacture of a medicament for detecting fungal infection in a human nail comprising an effective antifungal amount of said copper salt to stain fungal infected human nail tissue
  • the present invention is use of a copper salt in the manufacture of a medicament for preventing fungal infection in a healthy human nail comprising an effective antifungal amount of said copper salt.
  • the present invention is use of a copper salt in the manufacture of a medicament for preventing fungal growth on a healthy human nail comprising an effective antifungal amount of said copper salt.
  • the invention is a method for treating a fungal infection of a human nail comprising topically applying an effective antifungal amount of a composition comprising a copper salt to the nail, wherein the effective amount arrests fungal invasion of nail tissue.
  • the method utilizes one or more of the nail compositions disclosed herein.
  • the invention is a method for treating a fungal growth on a human nail comprising topically applying an effective antifungal amount of a composition comprising a copper salt to the nail, wherein the effective amount arrests fungal growth.
  • the method utilizes one or more of the nail compositions disclosed herein.
  • the invention is a method for persistent treatment of a fungal infection of a human nail comprising topically applying an effective antifungal amount of a composition comprising a copper salt to the nail, wherein the effective amount capable of arresting fungal invasion of nail tissue persists on the fungal infected nail tissue after repeated washing of the nail with a suitable solvent.
  • the method utilizes one or more of the nail compositions disclosed herein.
  • the invention is a method of detecting fungal infection in a human nail comprising topically applying an effective amount of a composition comprising a copper salt to the infected nail, wherein the composition visibly stains any fungal infected nail tissue; washing the infected nail with a suitable solvent to remove stain from uninfected nail tissue; and equating the persistent stained nail tissue with fungal infected nail tissue.
  • the method utilizes one or more of the nail compositions disclosed herein.
  • the invention is a method of monitoring fungal infection in a human nail comprising, at a first time point, topically applying an effective amount of a composition comprising a copper salt to the infected nail, wherein the composition visibly stains any fungal infected nail tissue; washing the nail with a suitable solvent to remove stain from uninfected nail tissue; equating the persistent stained nail tissue with fungal infected nail tissue; comparing the area of persistent stained nail tissue to the area of unstained nail tissue; at a second time point, topically applying an effective amount of a composition comprising a copper salt to the nail, wherein the composition stains any fungal infected nail tissue; washing the nail with a suitable solvent to remove stain from uninfected nail tissue; equating the persistent stained nail tissue with fungal infected nail tissue; comparing the area of persistent stained nail tissue to the area of unstained nail tissue; wherein an increase in the area ratio of unstained nail tissue to persistent stained nail tissue at said second time point to the area ratio of unstained nail
  • the invention is a method of preventing fungal infection in a healthy human nail comprising topically applying an effective antifungal amount of a composition comprising a copper salt to the nail, wherein the composition persists on the healthy nail after repeated washing of the nail with a suitable solvent.
  • the method utilizes one or more of the nail compositions disclosed herein.
  • the invention is a method of preventing fungal growth on a healthy human nail comprising topically applying an effective antifungal amount of a composition comprising a copper salt to the nail, wherein the composition persists on the healthy nail after repeated washing of the nail with a suitable solvent.
  • the method utilizes one or more of the nail compositions disclosed herein.
  • the present invention is a composition for treating human onychomycosis comprising an effective antifungal amount of at least one copper salt, such as copper sulfate, which is safe for topical application to human nail tissue and an acceptable carrier.
  • an effective antifungal amount of at least one copper salt such as copper sulfate
  • the composition of the present invention Upon application of the composition of the present invention to fungal infected human nail tissue, the fungal matter embedded in the infected nail is contacted with an effective antifungal amount of the copper salt(s).
  • the composition of the present invention remains in contact with the nail for an extended period of time.
  • Exemplary copper salts include but are not limited to copper acetates, copper ammonium complexes, copper carbonates, copper perchlorates, copper halides, copper gluconates, copper oxyhalides, copper lactates, copper naphthenates, copper oxides, copper quinolinates copper salicylates, copper selenates, copper sulfates, and copper tartrates can be used.
  • the copper salt is copper sulfate, also known in the art as copper sulfate, cupric sulfate, copper(II)sulfate, Roman vitriol, Fehling solution A, salzburg vitriol, sulfuric acid copper(2+) salt, blue copper, copper monosulfate, CuSO 4 , copper(2+)sulfate, cupric sulfate anhydrous, incracide E 51, blue stone, hi-chel, blue vitriol, natural chalcanthite, and other names.
  • copper sulfate utilized in the present invention is copper(II)sulfate pentahydrate.
  • the copper salts useful in the present invention are commercially available from general chemical suppliers such as Sigma Chemical Company (St. Louis, MO), Aldrich (Milwaukee, WI), and Mallinckrodt Laboratory Chemicals (Phillipsburg, NJ). It is understood that the present invention can utilize copper salts having a wide range of purity, including but not limited to industrial, technical, or reagent grade, provided that any impurity present in the copper salt is not harmful to humans on topical application.
  • the composition of present invention preferably comprises an amount of one or more copper salts equivalent to the amount of copper found in a 1-32% (weight/weight) aqueous composition of copper (II) sulfate at room temperature.
  • practical concentrations can vary from trace amounts to a paste of approximately 100% (weight/weight) of copper salts such as copper sulfate, depending upon the frequency of application, type of application, type of carrier used, and toxicity and/or patient sensitivity to the copper salt as disclosed herein.
  • the preferred concentration of copper salts useful in the present invention can vary depending upon the type of application, wherein the concentration of copper salt in a composition for the treatment of fungal infection is preferably higher than the concentration of copper salt used in nail polish or adhesive.
  • the preferred concentration of copper salt useful in the present invention for the treatment of fungal infection can vary depending upon the preferred treatment regimen. For example, a stronger concentration of copper salt is preferable in a composition which is infrequently applied; however, for a patient having sensitivity to copper salt, a composition with a lower concentration of copper salt applied more frequently would be preferred.
  • a preferred composition of the present invention comprises copper (I ⁇ )sulfate at a final concentration of about l%-32% (weight/weight); preferably, 7%-20% (weight/weight); most preferably, 10% (weight/weight) at room temperature.
  • An acceptable carrier useful in the composition of the present invention is any solvent system which stably solubilizes the copper salt and is tolerated by human tissue.
  • An acceptable carrier must solubilize the copper salt(s) and prevent subsequent recrystallization of the copper salt(s) over time.
  • Any carrier suitable for the active ingredient of the current invention is herein considered part of this application.
  • the cosmetic arts are rich in chemicals suitable for applying to human skin and nails. The following compounds are merely examples and not meant to be limiting in any way.
  • Carriers that may be used in conjunction with copper salts include moisturizers such as dimethicone silicone, isopropyl lanolate, lanolin, oleic acid, panthenal, and stearic acid.
  • Surfactants or detergents such as sodium laureth sulfate can be added to the copper salt composition of the present invention to provide foaming, cleansing, wetting, emulsifying, solubilizing, and dispersing properties to the solution.
  • Preservatives that may be used in a copper salt composition may include tocopherol and EDTA.
  • antimicrobials such as parabens, quaternium-15, methylisothiazolinone, DMDM hydantoin, and phenoxyethanol may also be used in a copper salt formulation. It may be advantageous to include thickeners, like microcrystalline waxes, polyethylene thickeners, and carbomer thickeners, in a copper salt composition.
  • Solvents that may be included in a copper salt formulation include water, a combination of water and glycerol, and a combination of water and a volatile organic solvent(s), including but not limited to butylene and propylene glycol, cyclomethicone, and glycerin.
  • Emulsifiers such as glyceryl monostearate, lauramide DEA, and polysorbates, may be advantageous to add to a copper salt composition.
  • penetrating agents can optionally be added. It is to be well understood that any person skilled in the art could choose appropriate surfactant, penetrating, moisturizing, antimicrobial, and emulsifying agents if desired to modify the copper salt composition, all of which are contemplated by the present invention.
  • an effective antifungal amount of copper salt(s) can also be added to existing nail products such as a commercially available nail polish (e.g., REVLON, New York, New York; L'Oreal USA, Inc., New York, New York, and CoverGirl, Procter & Gamble, Cincinnati, Ohio), acrylic nail products, gel nail products, cuticle softening solutions, nail conditioning preparations, or various products used in association with artificial nails or ornamentals.
  • a fixative the copper salt composition can be applied as a semi-permanent film to the nails prior to the application of nail polish, artificial nails or ornamentals.
  • composition of the present invention in a nail polish or as a film applied to the nails prior to the application of nail polish, artificial nails or ornamentals provides the advantage of having the copper salt- containing product remaining in contact with the nail for an extended period of time.
  • the nail polish can optionally comprise pigment when it is advantageous to minimize the appearance of staining of nail tissue caused by the copper salt. It is contemplated that one product or a combination of products comprising copper salt in an effective antifungal amount can be used.
  • the present invention is a method for treating onychomycosis in humans comprising applying a copper salt composition, preferably with an absorbent swab, felt, gauze, eyedropper or brush, to the fungal infected nail.
  • a copper salt composition preferably with an absorbent swab, felt, gauze, eyedropper or brush
  • the copper salt composition is applied for approximately 30 minutes and allowed to air dry.
  • a powder coating of copper salt covers the treated skin and nail.
  • the porous (infected) portion of the nail may be permanently stained from the copper salt, while normal nail tissue and skin is temporarily stained and returns to normal coloration.
  • a suitable solvent for washing is any solvent which is capable of solubilizing the copper salt without causing damage to the nail tissue or surrounding skin.
  • the washing solvent and the carrier in the copper salt composition can be the same or different.
  • copper (II) sulfate water is a preferred solvent for washing. Repeated washing of hands or feet over time generally results in further migration of the copper salt into the infected nail. Thus, normal washing does not interrupt the treatment process or require repeated application of the copper salt solution after each washing. As the treated nail grows, a narrow band having a reddish pink color may appear immediately behind the blue-stained infected nail portion. As new, healthy nail tissue appears, the stained infected portion of the nail grows beyond the nail bed and is trimmed away. Application of the copper salt composition is repeated upon fading of the stain, more preferably at least once monthly until signs of infection are eliminated.
  • the method to treat onychomycosis in humans can include processes that are generally part of nail health maintenance including trimming and sanding the nail, keeping the nail dry, and treating the affected areas with chemicals to enhance the absorption of and/or prevent the leaching out of the copper salt from the nail over time.
  • nail health maintenance including trimming and sanding the nail, keeping the nail dry, and treating the affected areas with chemicals to enhance the absorption of and/or prevent the leaching out of the copper salt from the nail over time.
  • clear or colored nail polish can be applied to the copper salt treated nail.
  • stained, treated nails can be cosmetically disguised by the application of colored nail polish.
  • Another aspect to the method of using a copper salt composition to treat human onychomycosis includes treating nails before they present the symptoms of onychomycosis. For example, if one toe nail exhibits the symptoms of onychomycosis, all toe nails can be treated even if symptoms are not yet apparent. Furthermore, since the copper salt composition will stain only the nail portions exhibiting fungal invasion, the progress of the fungal infection within one nail can be monitored, or possible spreading to other nails can be detected. For example, a staining copper salt, preferably copper sulfate, can be added to routine soaking solutions used in the art prior to manicuring or pedicuring.
  • the copper salt composition of the present invention can also be used to prevent onychomycosis as well as the growth of noninvasive fungi residing on the surface of human nails, for example, fungi commonly seen in association with the use of artificial nails or ornamentals.
  • a copper salt can be added to nail polish formulations, acrylic nail products, gel nail products, cuticle softening solutions, nail conditioning preparations, or various products used in association with artificial nails or ornamentals to effectively prevent the growth of fungi residing on the nail.
  • the copper salt composition can be applied as a semi-permanent film to the nails prior to the application of nail polish, artificial nails or ornamentals.
  • the copper salt can be applied in a time-release formulation. It is contemplated that one- product or a combination of products comprising copper salt can be used in the prevention of onychomycosis or superficial fungal growth.
  • One preferred method is a waterproof paper, plastic or foil package containing an absorbent swab or felt or gauze pad saturated with copper salt composition, whereupon tearing away a portion of the package exposes the copper salt composition saturated absorbent tip of the swab or a portion of the copper salt composition saturated felt or gauze pad which can be directly applied to the infected nail.
  • the copper salt composition is encapsulated in a breakable ampule, the breakable ampule is enclosed in a plyable container capable of confining the ampule upon breakage and having one sealed end and one opened end that is packed with an absorbent material, and the whole device is enclosed in a waterproof paper, plastic or foil package.
  • the ampule is broken to release the copper salt composition, the absorbent material is saturated with the copper salt composition, a portion of the package is torn away to expose the copper salt composition saturated absorbent material which can be directly applied to the infected nail.
  • Example 1 Toe Nail Treatment A male patient diagnosed as having a fungal infected toe nail, began treatment by applying an aqueous 10% (w/v) copper(II)sulfate pentahydrate solution to the infected nail using a copper sulfate saturated gauze pad. The copper sulfate solution was applied to the infected toe nail for approximately thirty minutes and then allowed to air dry. Excess copper sulfate powder was removed by washing two times with water. The infected portion of the patient's nail had a bluish color. As the treated nail grew, healthy nail tissue appeared at the base of the nail bed while the infected portion of the nail was pushed off the nail bed and periodically trimmed away. Over time, the fungal infection did not spread to healthy nail tissue and the stained, treated portion of the nail was removed.
  • Example 2 Toe Nail Treatment
  • a male patient diagnosed as having a fungal infected toe nail began treatment by applying with a cotton swab an aqueous 10% (w/v) copper(II)sulfate pentahydrate solution to the infected nail as well as to all nails on the same foot.
  • the copper sulfate solution was applied to Ms toe nails for approximately thirty minutes and then allowed to air dry. Excess copper sulfate powder was removed by washing two-three times with water.
  • the patient's infected nail had a bluish color where the infection was present. All other nails return to normal coloration, indicating that the fungal infection had not spread from the infected toe to neighboring toe nails on the same foot.
  • a female patient diagnosed as having a fungal infected fingernail began treatment by applying with a cotton swab an aqueous 10% (w/v) copper(II)sulfate pentahydrate solution to the infected nail as well as to all nails on the same hand.
  • the copper sulfate solution was applied to her fingernails for approximately thirty minutes and then allowed to air dry. Excess copper sulfate powder was removed by washing two-three times with water.
  • the patient's infected nail had a bluish color where the infection was present. All other nails returned to normal coloration, indicating that the fungal infection had not spread from the infected fingernail to neighboring fingernails on the same hand.
  • the patient routinely covered her fingernails in an opaque, colored nail enamel which completely disguised the infected nail.
  • healthy nail tissue appeared at the base of the nail bed while the infected portion of the nail was pushed off the nail bed and periodically trimmed away.
  • the copper sulfate solution was applied as given above to the infected fingernail and to all fingernails on the same hand.
  • the infected portion of the patient's nail continued to have a bluish color. All other nails returned to normal coloration on washing, indicating that the fungal infection still had not spread from the infected fingernail to neighboring fingernails on the same hand. Over time, the fungal infection did not spread to healthy nail tissue and the stained, treated portion of the nail was removed, resulting in a normal healthy nail.
  • the nail was separating from the nail bed along the right side of the nail and along the cuticle, leaving the nail hinged along the left side of the nail only.
  • the patient required a bandage to prevent the nail from tearing free.
  • the right side of the nail displayed the characteristic yellowing and rough, thick texture associated with the fungal infection.
  • a bandage was soaked with a preparation consisting of a 10% aqueous copper sulfate solution with a trace of detergent added to act as a surfactant.
  • the bandage was applied to the infected nail and secured in place. Care was given to ensure that the solution soaked into the crevice along the edge of the nail bed and cuticle. Subsequent hand washing provided additional wetting which drove more of the copper sulfate solution into the nail bed and surrounding crevice.
  • the bandage was worn for two days and then replaced with a clean dry bandage to protect the nail from snagging. The treatment was repeated on Day 31 and again on Day 45; no further treatments were given. Between treatments, the patient was permitted to resume the use of fingernail polish between treatments. On Day 132, the nail was examined. The patient was no longer wearing a dry bandage to protect the nail. New pink nail growth was present from the cuticle to a point midway along the nail.
  • the new portion of the nail was attached normally on both sides of the nail from the cuticle to the midpoint. There was a slight "keloid type” ridge across the nail at the midpoint. The old fungal infected nail was still separated from the midpoint of the right side of the nail to the end of the nail. The new growth immediately behind the "keloid type” ridge was rough in texture, typical of nail regrowth following a fungal infection. However, the nail newly emerging from the cuticle was smoother, like an uninfected nail.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Birds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)

Abstract

L'invention concerne un procédé servant à traiter l'onychomycose chez les humains et consistant à mettre en contact l'ongle infecté par un champignon avec une composition contenant une quantité efficace de sel de cuivre. On traite, dans un mode de réalisation préféré l'ongle infecté avec 10 % (poids/poids) de sulfate de cuivre (II) aqueux. On peut utiliser ce traitement afin de détecter l'infection fongique avant l'apparition de symptômes physiques habituels. On prévient aussi cette infection fongique par traitement préalable des ongles au moyen de cette composition de sel de cuivre.
PCT/US2001/029438 2000-11-16 2001-09-19 Composition servant a traiter l'infection de l'ongle par un champignon et son procede d'utilisation WO2002039963A1 (fr)

Priority Applications (6)

Application Number Priority Date Filing Date Title
MXPA03005380A MXPA03005380A (es) 2000-11-16 2001-09-19 Composicion antifungica para unas y metodo para su uso.
JP2002542338A JP2004513905A (ja) 2000-11-16 2001-09-19 抗真菌爪用組成物および使用方法
CA002431651A CA2431651A1 (fr) 2000-11-16 2001-09-19 Composition servant a traiter l'infection de l'ongle par un champignon et son procede d'utilisation
EP01973268A EP1341500A1 (fr) 2000-11-16 2001-09-19 Composition servant a traiter l'infection de l'ongle par un champignon et son procede d'utilisation
AU2001292866A AU2001292866A1 (en) 2000-11-16 2001-09-19 Antifungal nail composition and method of use
US10/440,468 US20040001791A1 (en) 2000-11-16 2003-05-16 Composition, method of use, and devices for the treatment of onychomycosis

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US24938100P 2000-11-16 2000-11-16
US60/249,381 2000-11-16
US28678101P 2001-04-26 2001-04-26
US60/286,781 2001-04-26

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US10/440,468 Continuation-In-Part US20040001791A1 (en) 2000-11-16 2003-05-16 Composition, method of use, and devices for the treatment of onychomycosis

Publications (1)

Publication Number Publication Date
WO2002039963A1 true WO2002039963A1 (fr) 2002-05-23

Family

ID=26940019

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2001/029438 WO2002039963A1 (fr) 2000-11-16 2001-09-19 Composition servant a traiter l'infection de l'ongle par un champignon et son procede d'utilisation

Country Status (6)

Country Link
EP (1) EP1341500A1 (fr)
JP (1) JP2004513905A (fr)
AU (1) AU2001292866A1 (fr)
CA (1) CA2431651A1 (fr)
MX (1) MXPA03005380A (fr)
WO (1) WO2002039963A1 (fr)

Cited By (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003043971A1 (fr) * 2001-11-19 2003-05-30 Isagro S.P.A. Compositions a base de sels cuivriques, sels cuivriques, et leur utilisation dans l'elimination des phytopathogenes
WO2003088983A1 (fr) * 2002-04-17 2003-10-30 Conve Ltd Utilisation de compositions topiques dans la lutte contre des maladies microbiennes de l'ongle
WO2014150719A1 (fr) 2013-03-15 2014-09-25 Cda Research Group, Inc. Traitements topiques aux ions de cuivre dans les zones dermatologiques du corps
JP2018513186A (ja) * 2015-04-24 2018-05-24 メディカル リサーチ カウンシルＭｅｄｉｃａｌ Ｒｅｓｅａｒｃｈ Ｃｏｕｎｃｉｌ オキソ水酸化銅ナノ粒子を含む抗細菌組成物およびそれらの殺生物剤としての使用
US10813948B2 (en) 2013-03-15 2020-10-27 Cda Research Group, Inc. Methods of treatment using topical copper ion formulations
US10998467B2 (en) 2019-09-25 2021-05-04 Nano Sono Cooperation Ltd. Compositions of metal oxide semiconductor nanomaterials and hemostatic polymers
US10995011B2 (en) 2019-01-17 2021-05-04 Nano Sono Cooperation Ltd. Compositions of metal oxide semiconductor nanomaterials
US11000545B2 (en) 2013-03-15 2021-05-11 Cda Research Group, Inc. Copper ion compositions and methods of treatment for conditions caused by coronavirus and influenza
US11007143B2 (en) 2013-03-15 2021-05-18 Cda Research Group, Inc. Topical copper ion treatments and methods of treatment using topical copper ion treatments in the oral-respiratory-otic areas of the body
EP3761990A4 (fr) * 2018-03-09 2021-12-01 Therazure LLC Compositions pour le traitement d'infections au niveau des pieds
US11193184B2 (en) 2019-02-22 2021-12-07 Cda Research Group, Inc. System for use in producing a metal ion suspension and process of using same
US11318089B2 (en) 2013-03-15 2022-05-03 Cda Research Group, Inc. Topical copper ion treatments and methods of making topical copper ion treatments for use in various anatomical areas of the body
US11730824B2 (en) 2019-01-17 2023-08-22 Nsc Nano Sono Cooperation Ltd. Drug-releasing compositions of metal oxide semiconductor nanomaterials and hemostatic polymers
US11820672B2 (en) 2019-01-17 2023-11-21 Nano Sono Cooperation Ltd. Processes for preparing metal oxide semiconductor nanomaterials

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102771170B1 (ko) * 2016-03-08 2025-02-24 유니버시티 오브 유타 리서치 파운데이션 가교-결합제 및 관련 방법

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3257280A (en) * 1963-08-26 1966-06-21 Richter Aron Gelatin and copper chelate nail bodying compositions and methods
RO88114A2 (fr) * 1983-08-17 1985-12-30 Intreprinderea De Produse Cosmetice"Miraj",Ro Produit cosmetique pour le durcissement des ongles fragiles
US4822595A (en) * 1986-08-19 1989-04-18 Corliss Lyal S Hoof lotion
US4933175A (en) * 1988-07-28 1990-06-12 De'jeuner, Inc. Process and product for preparing human nail strengthening composition
WO1993011735A1 (fr) * 1991-12-18 1993-06-24 Advanced Oxygen Technologies, Inc. Traitement d'infections fongiques
RU2063744C1 (ru) * 1992-02-13 1996-07-20 Товарищество с ограниченной ответственностью "Фитолон" Лосьон для укрепления ногтей
WO1998052927A1 (fr) * 1997-05-19 1998-11-26 Rosemarie Scivoletto Preparations pour le traitement des troubles cutanes

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3257280A (en) * 1963-08-26 1966-06-21 Richter Aron Gelatin and copper chelate nail bodying compositions and methods
RO88114A2 (fr) * 1983-08-17 1985-12-30 Intreprinderea De Produse Cosmetice"Miraj",Ro Produit cosmetique pour le durcissement des ongles fragiles
US4822595A (en) * 1986-08-19 1989-04-18 Corliss Lyal S Hoof lotion
US4933175A (en) * 1988-07-28 1990-06-12 De'jeuner, Inc. Process and product for preparing human nail strengthening composition
WO1993011735A1 (fr) * 1991-12-18 1993-06-24 Advanced Oxygen Technologies, Inc. Traitement d'infections fongiques
RU2063744C1 (ru) * 1992-02-13 1996-07-20 Товарищество с ограниченной ответственностью "Фитолон" Лосьон для укрепления ногтей
WO1998052927A1 (fr) * 1997-05-19 1998-11-26 Rosemarie Scivoletto Preparations pour le traitement des troubles cutanes

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
DATABASE WPI Section Ch Week 198630, Derwent World Patents Index; Class D21, AN 1986-195058, XP002193017 *
DATABASE WPI Section Ch Week 199714, Derwent World Patents Index; Class D21, AN 1997-152592, XP002193016 *
H. M. BUTLER ET AL: "The use of phenanthroline metal chelates for the control of topical infections due to bacteria, fungi and protozoa", MEDICAL JOURNAL OF AUSTRALIA., vol. 2, 1970, pages 309 - 314, XP008001374 *

Cited By (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003043971A1 (fr) * 2001-11-19 2003-05-30 Isagro S.P.A. Compositions a base de sels cuivriques, sels cuivriques, et leur utilisation dans l'elimination des phytopathogenes
US8637058B2 (en) 2001-11-19 2014-01-28 Isagro S.P.A. Compositions based on cupric salts, cupric salts and their use for controlling phytopathogens
WO2003088983A1 (fr) * 2002-04-17 2003-10-30 Conve Ltd Utilisation de compositions topiques dans la lutte contre des maladies microbiennes de l'ongle
AP1777A (en) * 2002-04-17 2007-09-03 Conve Ltd Use of topical compositions for the control of microbial diseases of the nail.
US11000545B2 (en) 2013-03-15 2021-05-11 Cda Research Group, Inc. Copper ion compositions and methods of treatment for conditions caused by coronavirus and influenza
US11007143B2 (en) 2013-03-15 2021-05-18 Cda Research Group, Inc. Topical copper ion treatments and methods of treatment using topical copper ion treatments in the oral-respiratory-otic areas of the body
EP3003046A4 (fr) * 2013-03-15 2017-03-29 CDA Research Group, Inc. Traitements topiques aux ions de cuivre dans les zones dermatologiques du corps
US11717535B2 (en) 2013-03-15 2023-08-08 Cda Research Group, Inc. Copper ion compositions and methods of treatment for conditions caused by coronavirus and influenza
US10398733B2 (en) 2013-03-15 2019-09-03 Cda Research Group, Inc. Topical copper ion treatments and methods of treatment using topical copper ion treatments in the dermatological areas of the body
US10813948B2 (en) 2013-03-15 2020-10-27 Cda Research Group, Inc. Methods of treatment using topical copper ion formulations
US12171867B2 (en) 2013-03-15 2024-12-24 Cda Research Group, Inc. Topical copper ion treatments and methods of making topical copper ion treatments for use in various anatomical areas of the body
EP3003046A1 (fr) * 2013-03-15 2016-04-13 CDA Research Group, Inc. Traitements topiques aux ions de cuivre dans les zones dermatologiques du corps
WO2014150719A1 (fr) 2013-03-15 2014-09-25 Cda Research Group, Inc. Traitements topiques aux ions de cuivre dans les zones dermatologiques du corps
US11857514B2 (en) 2013-03-15 2024-01-02 Cda Research Group, Inc. Topical copper ion treatments and methods of treatment using topical copper ion treatments in the dermatological areas of the body
US11083750B2 (en) 2013-03-15 2021-08-10 Cda Research Group, Inc. Methods of treatment using topical copper ion formulations
US11318089B2 (en) 2013-03-15 2022-05-03 Cda Research Group, Inc. Topical copper ion treatments and methods of making topical copper ion treatments for use in various anatomical areas of the body
US11298316B2 (en) 2013-03-15 2022-04-12 Cda Research Group, Inc. Topical copper ion treatments and methods of treatment using topical copper ion treatments in the oral-respiratory-otic areas of the body
US11253544B2 (en) 2013-03-15 2022-02-22 Cda Research Group, Inc. Methods of treatment using topical copper ion formulations
JP2018513186A (ja) * 2015-04-24 2018-05-24 メディカル リサーチ カウンシルＭｅｄｉｃａｌ Ｒｅｓｅａｒｃｈ Ｃｏｕｎｃｉｌ オキソ水酸化銅ナノ粒子を含む抗細菌組成物およびそれらの殺生物剤としての使用
US12053486B2 (en) 2018-03-09 2024-08-06 Therazure LLC Compositions for the treatment of infections in feet
EP3761990A4 (fr) * 2018-03-09 2021-12-01 Therazure LLC Compositions pour le traitement d'infections au niveau des pieds
US10995011B2 (en) 2019-01-17 2021-05-04 Nano Sono Cooperation Ltd. Compositions of metal oxide semiconductor nanomaterials
US11730824B2 (en) 2019-01-17 2023-08-22 Nsc Nano Sono Cooperation Ltd. Drug-releasing compositions of metal oxide semiconductor nanomaterials and hemostatic polymers
US11820672B2 (en) 2019-01-17 2023-11-21 Nano Sono Cooperation Ltd. Processes for preparing metal oxide semiconductor nanomaterials
US11459638B2 (en) 2019-02-22 2022-10-04 Cda Research Group, Inc. System for use in producing a metal ion suspension and process of using same
US11193184B2 (en) 2019-02-22 2021-12-07 Cda Research Group, Inc. System for use in producing a metal ion suspension and process of using same
US10998467B2 (en) 2019-09-25 2021-05-04 Nano Sono Cooperation Ltd. Compositions of metal oxide semiconductor nanomaterials and hemostatic polymers

Also Published As

Publication number Publication date
EP1341500A1 (fr) 2003-09-10
AU2001292866A1 (en) 2002-05-27
JP2004513905A (ja) 2004-05-13
CA2431651A1 (fr) 2002-05-23
MXPA03005380A (es) 2004-02-18

Similar Documents

Publication Publication Date Title
US5736582A (en) Method and composition for controlled delivery of nascent oxygen from hydrogen peroxide source for skin treatment
US5958984A (en) Method and composition for skin treatment
WO2002039963A1 (fr) Composition servant a traiter l'infection de l'ongle par un champignon et son procede d'utilisation
US4777034A (en) Compositions for counteracting the degradations and inconvenience of perspiration
WO2001047357A1 (fr) Systeme en une etape pour nettoyer, tonifier et traiter la peau
CN1175206A (zh) 用于减轻皮肤刺激作用的制剂和方法
CA2243566A1 (fr) Laque antifongique pour ongles et methode connexe
US5853768A (en) Topical preparation and method for pain relief
US5916574A (en) Method of treating natural poison skin conditions
US4234566A (en) Antihistamine and methods for use thereof
US20160235847A1 (en) Nail fungus treatment and composition
US20040001791A1 (en) Composition, method of use, and devices for the treatment of onychomycosis
US5565189A (en) Wound cleanser method of use
EP0812193B1 (fr) Compositions pharmaceutiques contenant une benzydamine ou son sel et un agent antimicrobien
US3725525A (en) Hair and nail hardening process
US5973010A (en) Composition for healing skin wounds
US4226850A (en) Methods for controlling perspiration
EP1586336A1 (fr) Composé contenant du cuivre et des produits de soja
ITMI941680A1 (it) Estratto vegetale contro le ustioni
JP2003055138A (ja) プロポリス含有シート状化粧料
MXPA03002092A (es) Solucion topica terapeutica para la piel y metodo asociado de uso.
KR880013563A (ko) 히드록시알킬포스핀화합물의 제약학, 수의학 및 미용상의 용도
JP2766811B2 (ja) 水性皮膚外用剤
JP3492753B2 (ja) 浴用剤組成物
KR100768401B1 (ko) 무좀방지용 화장료 조성물

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 10440468

Country of ref document: US

Ref document number: 2002542338

Country of ref document: JP

WWE Wipo information: entry into national phase

Ref document number: 2001292866

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: PA/a/2003/005380

Country of ref document: MX

Ref document number: 2001973268

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2431651

Country of ref document: CA

WWP Wipo information: published in national office

Ref document number: 2001973268

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWW Wipo information: withdrawn in national office

Ref document number: 2001973268

Country of ref document: EP

点击 这是indexloc提供的php浏览器服务，不要输入任何密码和下载